Mr Peter Nolan





Oxford BioMedica (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs.


Organisation Type
Oxford BioMedica plc
SVP -Commercial Development